|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2024
As of Sep 30, 2024
|
Q4 FY2024
As of Dec 31, 2024
|
Q2 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Current assets: | ||||||||||||||||||
| Accounts receivable ($0 and $1,567 from related parties, respectively) | ||||||||||||||||||
| Cash | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Prepaid insurance, long-term | ||||||||||||||||||
| Marketable securities held in Trust Account | ||||||||||||||||||
| Total marketable securities held in Trust Account | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||
| Other non-current assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| Current liabilities: | ||||||||||||||||||
| Accrued expenses | ||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||
| Accrued interest payable – related party | ||||||||||||||||||
| Accrued offering costs | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||
| Deferred legal fees | ||||||||||||||||||
| Operating lease liability, current | ||||||||||||||||||
| Equity line of credit commitment payable | ||||||||||||||||||
| Other liabilities | ||||||||||||||||||
| Forward purchase agreement settlement liability | ||||||||||||||||||
| Convertible promissory notes, current ($300 to related parties) | ||||||||||||||||||
| Senior secured notes, current | ||||||||||||||||||
| Note payable - related party, current | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Convertible note - related party | ||||||||||||||||||
| Deferred legal fee | ||||||||||||||||||
| Deferred underwriting fee payable | ||||||||||||||||||
| Forward purchase agreement derivative liability | ||||||||||||||||||
| Senior secured notes | ||||||||||||||||||
| Non-current liabilities | ||||||||||||||||||
| Note payable - related party, non-current | ||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||
| Other liabilities | ||||||||||||||||||
| Convertible promissory notes, current ($300 to related parties) | ||||||||||||||||||
| Senior secured notes, current | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Stockholders’ equity (deficit) | ||||||||||||||||||
| Convertible preferred stock value | ||||||||||||||||||
| Carrying amount | ||||||||||||||||||
| Series A Convertible Preferred Stock | ||||||||||||||||||
| Series C Convertible Preferred Stock | ||||||||||||||||||
| Series D Convertible Preferred Stock | ||||||||||||||||||
| Total carrying amount | ||||||||||||||||||
| Common Stock, $0.0001 par value; 600,000,000 shares authorized; 187,328,921 and 172,318,506 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||
| Common Class A | ||||||||||||||||||
| Common Class B | ||||||||||||||||||
| Total common Stock, $0.0001 par value; 600,000,000 shares authorized; 187,328,921 and 172,318,506 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Total stockholders’ equity (deficit) | ||||||||||||||||||
| Total liabilities and stockholders’ equity (deficit) | ||||||||||||||||||
Loading...
